Travel Vaccines Market - Forecast(2024 - 2030)

Report Code: HCR 1414 Report Format: PDF + Excel

Travel Vaccines Market Overview

Travel Vaccines market size is forecast to reach $8.7 billion by 2026, growing at a CAGR of 7.2% during the forecast period 2021-2026. Travel vaccine, also known as travel immunizations, are injections that passengers will receive when reaching some parts of the planet. These travel vaccinations assist passengers all around the globe in avoiding severe illnesses. The vaccine works by exposing the body to the germs of the disease from which the individual is being vaccinated.

The body produces antibodies in response to the vaccine, which protect the body from disease exposure. The effectiveness of vaccine formulations is primarily determined by the vaccine stain, vaccine schedule, disease pathophysiology, and genetic predisposition. There are various vaccines available such as Combination Vaccines, Attenuated Vaccines, Inactive Vaccines, Toxoid Vaccines and others. 

Rising prevalence of various diseases across the globe coupled with increasing number of travelers are the major factors driving the growth of the market. Growing research & development activities improving healthcare facilities is set to further enhance the overall market development of the Travel Vaccines Market for the period 2021-2026.

Travel Vaccines Market Report Coverage

The report: Travel Vaccines Market Forecast (2021-2026), by Industry ARC, covers an in-depth analysis of the following segments of the Travel Vaccines Market.

By Type: Combination Vaccines, Attenuated Vaccines, Inactive Vaccines, Toxoid Vaccines, Others.
By Disease: Hepatitis A, Hepatitis B, Rabies, Typhoid, Influenza, Polio, Yellow Fever, Others.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (Middle East, and Africa).

Key Takeaways

  • North America dominated the Travel Vaccines Market in 2020 owing to the wide availability of advanced technologies and favorable reimbursement policies. The Travel Vaccines Market scope for different regions will be provided in the final report.
  • Increasing healthcare expenditure and technological advancement along with the new innovations are likely to aid the market growth of the Travel Vaccines Market report.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Travel Vaccines Market report.
  • High cost of vaccines and lack of skilled and trained healthcare professionals is poised to create the hurdles for the Travel Vaccines Market.

Travel Vaccines Market Revenue Share, By Geography, 2020(%)

For More Details on This Report - Request for Sample

Travel Vaccines Market Segment Analysis – By Type

The Inactive Vaccines segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 7.8% during the forecast period 2020-2025. An inactivated vaccine is one that is made up of virus spores, bacteria, or other viruses that have been grown in culture and then destroyed to remove their ability to cause disease. It does not contain any live components hence it provide more benefits than Combination Vaccines, Attenuated Vaccines, Toxoid Vaccines and other vaccines. Inactive Vaccines target various viruses such as polio, hepatitis A, and rabies. Inactive Vaccines are estimated to register the higher CAGR over the period 2021-2026.

Travel Vaccines Market Segment Analysis – By Disease

Influenza held the largest share in the Travel Vaccines Market in 2020 and is estimated to grow at a CAGR 8.1% during the forecast period 2021-2026. Influenza is a contagious bacterial infection caused by influenza viruses. The symptoms includes headache, runny nose, fever, sore throat, muscle pain, coughing, and fatigue. This disease is occurs all over the world and spreads rapidly in communities, particularly in densely populated areas. Travellers are highly advised to get the influenza vaccine, particularly if flu outbreaks are prevalent in the destination area. Influenza are estimated to register the higher CAGR over the period 2021-2026.

Travel Vaccines Market Segment Analysis – By Geography

North America dominated the Travel Vaccines Market with a major share of 37.3% in 2020. This is owing to increasing number of travel related diseases such as yellow fever, diphtheria, Hepatitis in this region. According to, Hepatitis B Foundation, in U.S. around 80,000 people affected with hepatitis B per year is also increasing the growth of the market in this region.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the development of health infrastructures and increasing awareness of health care. Increasing awareness of travel vaccine is also contributing to the growth in this region

Travel Vaccines Market Drivers

Increasing Number of Travellers

Increasing number of travellers in worldwide is increasing the growth of the Travel Vaccines Market. This is attributed to the development of the technologically advanced vaccines with extended longevity. According to, World Health Organization (WHO), International travel is increasing, with millions of people traveling each year for educational, religious, recreational, and humanitarian reasons. Furthermore, in some countries, Global regulatory agencies have now requested that travellers be vaccinated when visiting disease-prone areas. Thus, further contributing to the growth of Travel Vaccines Market during the forecast period 2021-2026.

Technological Advancements

Technological advancements is increasing the growth of the Travel Vaccines Market. Technological advancements has enabled the manufacturers to develop vaccines with more research & development. Increasing advancements in Travel Vaccines has provided an opportunity for development of vaccine with strong immunity. Thus, increasing the growth of the Travel Vaccines Market during the forecast period 2021-2026.

Travel Vaccines Market Challenges

High Cost of Vaccine

Factors which restrain the growth of the Travel Vaccines Market are lack of skilled and trained healthcare professionals. High cost of Travel Vaccines, lack of compensation policy, and high initial investment is also set to hinder the growth of the market.

Travel Vaccines Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Travel Vaccines Market. In 2020, the Travel Vaccines Market share is consolidated by the top ten players present in the market. The Travel Vaccines Market, top 10 companies are Novartis, Sanofi Pasteur, Merck & Co. Inc., Pfizer, Abbott, GSK group, F. Hoffman-La Roche Ltd., Baxter International, Inc. and Zydus Cadila

Relevant Titles:

Therapeutic Vaccine Market - Forecast(2021 - 2026)
Report Code: HCR 0397

Influenza Vaccine Market - Forecast(2021 - 2026)
Report Code: HCR 0226

For more Lifesciences and Healthcare Market reports, please click here

1. Travel Vaccines Market - Overview
    1.1 Definitions and Scope
2. Travel Vaccines Market - Executive Summary
    2.1 Market Revenue and Key Trends
    2.2 Key trends by Type
    2.3 Key trends by Disease
    2.4 Key trends by Geography
3. Travel Vaccines Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis –
    3.5 Pricing Analysis
4. Travel Vaccines Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Travel Vaccines Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Travel Vaccines Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Travel Vaccines Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Travel Vaccines Market – By Type(Market Size –$Million/$Billion)
    8.1 Combination Vaccines
    8.2 Attenuated Vaccines
    8.3 Inactive Vaccines
    8.4 Toxoid Vaccines
    8.5 Others
9. Travel Vaccines Market - By Disease(Market Size –$Million/$Billion)
    9.1 Hepatitis A
    9.2 Hepatitis B
    9.3 Rabies
    9.4 Typhoid
    9.5 Influenza
    9.6 Polio
    9.7 Yellow Fever
    9.8 Others
10. Travel Vaccines Market - By Geography(Market Size –$Million/$Billion
    10.1 North America
        10.1.1 U.S.
        10.1.2 Mexico
        10.1.3 Canada
    10.2 Europe
        10.2.1 U.K.
        10.2.2 France
        10.2.3 Germany
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia Pacific
        10.3.1 China
        10.3.2 India
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 Australia & New Zealand
        10.3.6 Rest of APAC
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Others
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Travel Vaccines Market - Entropy
12. Travel Vaccines Market – Industry/Segment Competition Landscape Premium
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key companies
        12.1.3 Market Share by Countries – Key Companies
        12.1.4 Best Practices for Companies
13. Travel Vaccines Market – Key Company List by Country Premium Premium
14. Travel Vaccines Market Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.